Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:238-247

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pratt, R. E.
Right arrow Articles by Dzau, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pratt, R. E.
Right arrow Articles by Dzau, V. J.

(Hypertension. 1999;33:238-247.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Genomics and Hypertension

Concepts, Potentials, and Opportunities

Richard E. Pratt; Victor J. Dzau

From the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Richard E. Pratt, PhD and Victor J. Dzau, MD, Laboratory of Genetic Physiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. E-mail rpratt{at}bustoff.bwh.harvard.edu

Abstract—We are at the beginning of a biological revolution, spurred on by the Human Genome Project and associated studies. Within the next few years, expressed sequence tags (ESTs) representing all sequences expressed in humans will be determined and their genomic positions will be defined (STSs). The discovery of all the variants in the human genome that contribute to the genetic diversity of the human population will result in the construction of dense polymorphic maps. The rapid growth of the EST, STS, and single-nucleotide polymorphism (SNP) databases, coupled with impressive technological advances, will surely have a dramatic effect on biomedical research. In this review, we will examine the recent advances in genetics and genomics and place these within the context of medical research and patient care, with an emphasis on studies in the cardiovascular system.


Key Words: Human Genome Project • gene expression • genes • polymorphism, single-nucleotide • genetics • pharmacogenomics • proteomics




This article has been cited by other articles:


Home page
CirculationHome page
J. V. Gainer, A. Bellamine, E. P. Dawson, K. E. Womble, S. W. Grant, Y. Wang, L. A. Cupples, C.-Y. Guo, S. Demissie, C. J. O'Donnell, et al.
Functional Variant of CYP4A11 20-Hydroxyeicosatetraenoic Acid Synthase Is Associated With Essential Hypertension
Circulation, January 4, 2005; 111(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. V. Podgoreanu and D. A. Schwinn
Genomics and the circulation
Br. J. Anaesth., July 1, 2004; 93(1): 140 - 148.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C.-M. Huang, J. J.P. Tsai, F.-J. Tsai, W.-C. Chen, and C.-L. Chen
Letter to the Editor
Lupus, May 1, 2003; 12(5): 423 - 424.
[PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Nakagawa, J. S. Marji, M. L. Schwartzman, M. R. Waterman, and J. H. Capdevila
Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1055 - R1062.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
W. C. Aird, S. B. Glueck, V. J. Dzau, and R. E. Pratt
Separating the wheat from the chaff: Focus on "In silico data filtering to identify new angiogenesis targets from a large in vitro gene profile data set"
Physiol Genomics, July 12, 2002; 10(1): 1 - 3.
[Full Text] [PDF]


Home page
Eur Heart JHome page
B. Swynghedauw
Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes
Eur. Heart J., February 2, 2002; 23(4): 271 - 273.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. B. GLUECK, V. J. DZAU, R. LEE, and R. E. PRATT
Challenges of comparative expression profiling studies of complex diseases: mouse models of myocardial hypertrophy Focus on "Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy"
Physiol Genomics, June 6, 2001; 6(1): 1 - 2.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. R. Holla, F. Adas, J. D. Imig, X. Zhao, E. Price Jr., N. Olsen, W. J. Kovacs, M. A. Magnuson, D. S. Keeney, M. D. Breyer, et al.
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension
PNAS, April 24, 2001; 98(9): 5211 - 5216.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. J. Dzau, M. J. Mann, A. Ehsan, and D. P. Griese
Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0206 - 216.
[Full Text] [PDF]


Home page
Public Understanding of ScienceHome page
F. Jackson
African-American responses to the Human Genome Project
Public Understanding of Science, July 1, 1999; 8(3): 181 - 191.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Sesti, G. W. Abbott, J. Wei, K. T. Murray, S. Saksena, P. J. Schwartz, S. G. Priori, D. M. Roden, A. L. George Jr., and S. A. N. Goldstein
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
PNAS, September 12, 2000; 97(19): 10613 - 10618.
[Abstract] [Full Text] [PDF]